BACKGROUND: While others have described gene expression patterns in humans with inflammatory bowel diseases and animals with chemically induced colitis, a genome-wide comparison of gene expression in genetically susceptible animals that develop spontaneous colitis has not been reported. METHODS: We used microarray technology to compare gene expression profiles in cecal specimens from specific pathogen-free IL10-deficient (IL10-/-) mice with colitis and normal wildtype (WT) mice. RNA isolated from ceca of IL10-/- and WT mice was subjected to microarray analysis. The results were confirmed by real-time polymerase chain reaction (PCR) and immunofluorescence microscopy of selected molecules. Expression of the selected genes in dextran sodium sulfate (DSS)-treated mice with colitis and epithelial cell lines activated with pathophysiologic stimuli was measured by real-time PCR. RESULTS: Histological inflammation of the colon and IL-12/23p40 secretion from intestinal explants were greater in IL10-/- and DSS-treated mice versus WT and untreated mice. Microarray analysis demonstrated >10-fold induction of the following molecules in the ceca of IL10-/- mice: mitochondrial ribosomal protein-L33, aquaporin-4, indoleamine-pyrrole-2,3-dioxygenase, and MHC class II with 63, 25, 20, and 12-fold increases, respectively. Cytochrome-P450, pancreatic lipase-related protein-2, and transthyretin were downregulated in IL10-/- mice. MHC II was increased throughout the colon, and aquaporin-4 was increased in the basolateral aspect of cecal epithelial cells. MHC II mRNA was increased in epithelial cells treated with IFN-gamma, but not TNF or Toll-like receptor ligands. CONCLUSIONS: Although most upregulated genes in experimental colitis are immune-related, aquaporin-4 and mitochondrial ribosomal protein-L33, which have not been previously associated with inflammation, were most highly upregulated.
BACKGROUND: While others have described gene expression patterns in humans with inflammatory bowel diseases and animals with chemically induced colitis, a genome-wide comparison of gene expression in genetically susceptible animals that develop spontaneous colitis has not been reported. METHODS: We used microarray technology to compare gene expression profiles in cecal specimens from specific pathogen-free IL10-deficient (IL10-/-) mice with colitis and normal wildtype (WT) mice. RNA isolated from ceca of IL10-/- and WT mice was subjected to microarray analysis. The results were confirmed by real-time polymerase chain reaction (PCR) and immunofluorescence microscopy of selected molecules. Expression of the selected genes in dextran sodium sulfate (DSS)-treated mice with colitis and epithelial cell lines activated with pathophysiologic stimuli was measured by real-time PCR. RESULTS: Histological inflammation of the colon and IL-12/23p40 secretion from intestinal explants were greater in IL10-/- and DSS-treated mice versus WT and untreated mice. Microarray analysis demonstrated >10-fold induction of the following molecules in the ceca of IL10-/- mice: mitochondrial ribosomal protein-L33, aquaporin-4, indoleamine-pyrrole-2,3-dioxygenase, and MHC class II with 63, 25, 20, and 12-fold increases, respectively. Cytochrome-P450, pancreatic lipase-related protein-2, and transthyretin were downregulated in IL10-/- mice. MHC II was increased throughout the colon, and aquaporin-4 was increased in the basolateral aspect of cecal epithelial cells. MHC II mRNA was increased in epithelial cells treated with IFN-gamma, but not TNF or Toll-like receptor ligands. CONCLUSIONS: Although most upregulated genes in experimental colitis are immune-related, aquaporin-4 and mitochondrial ribosomal protein-L33, which have not been previously associated with inflammation, were most highly upregulated.
Authors: George D Leikauf; Susan A McDowell; Scott C Wesselkamper; William D Hardie; John E Leikauf; Thomas R Korfhagen; Daniel R Prows Journal: Chest Date: 2002-03 Impact factor: 9.410
Authors: C Veltkamp; S L Tonkonogy; Y P De Jong; C Albright; W B Grenther; E Balish; C Terhorst; R B Sartor Journal: Gastroenterology Date: 2001-03 Impact factor: 22.682
Authors: E C Koc; W Burkhart; K Blackburn; M B Moyer; D M Schlatzer; A Moseley; L L Spremulli Journal: J Biol Chem Date: 2001-09-10 Impact factor: 5.157
Authors: C B Larmonier; D Laubitz; R D Thurston; A L Bucknam; F M Hill; M Midura-Kiela; R Ramalingam; P R Kiela; F K Ghishan Journal: Am J Physiol Gastrointest Liver Physiol Date: 2011-03-17 Impact factor: 4.052
Authors: Ting-Jia Fan; Sandrine Y Tchaptchet; Diana Arsene; Yoshiyuki Mishima; Bo Liu; R Balfour Sartor; Ian M Carroll; Edward A Miao; Anthony A Fodor; Jonathan J Hansen Journal: Inflamm Bowel Dis Date: 2018-10-12 Impact factor: 5.325
Authors: I J J Claes; Sarah Lebeer; C Shen; T L A Verhoeven; E Dilissen; G De Hertogh; D M A Bullens; J L Ceuppens; G Van Assche; S Vermeire; P Rutgeerts; J Vanderleyden; S C J De Keersmaecker Journal: Clin Exp Immunol Date: 2010-08-20 Impact factor: 4.330
Authors: Stephen F Murphy; Lesley Rhee; Wesley A Grimm; Christopher R Weber; Jeannette S Messer; James P Lodolce; Jonathan E Chang; Sarah J Bartulis; Thomas Nero; Renata A Kukla; Gordon MacDougall; Charles Binghay; Lauren E Kolodziej; David L Boone Journal: Am J Physiol Gastrointest Liver Physiol Date: 2014-09-18 Impact factor: 4.052
Authors: Matthew P G Barnett; Warren C McNabb; Adrian L Cookson; Shuotun Zhu; Marcus Davy; Bianca Knoch; Katia Nones; Alison J Hodgkinson; Nicole C Roy Journal: BMC Immunol Date: 2010-07-15 Impact factor: 3.615